Inspire Advisors, LLC Adaptimmune Therapeutics PLC Transaction History
Inspire Advisors, LLC
- $919 Million
- Q3 2025
Shares
3 transactions
Others Institutions Holding ADAP
# of Institutions
65Shares Held
91.3MCall Options Held
907Put Options Held
0-
Long Focus Capital Management, LLC San Juan, PR18.6MShares$557,3340.1% of portfolio
-
Ubs Group Ag6.67MShares$200,0200.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny4.05MShares$121,6220.0% of portfolio
-
Morgan Stanley New York, NY3.67MShares$109,9810.0% of portfolio
-
Jane Street Group, LLC New York, NY2.81MShares$84,1600.0% of portfolio
About Adaptimmune Therapeutics PLC
- Ticker ADAP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 163,370,000
- Market Cap $4.9M
- Description
- Adaptimmune Therapeutics plc, a clinical-stage biopharmaceutical company, focuses on providing novel cell therapies primarily to patients with solid tumors in the United States and the United Kingdom. The company's specific peptide enhanced affinity receptor (SPEAR) T-cell platform enables it to identify cancer targets. It is developing ADP-A2M4...